← All tickers

Is LXRX Worth Buying in 2026?

Lexicon Pharmaceuticals, Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-23

Here’s whether Lexicon Pharmaceuticals, Inc. (LXRX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.48% over 10 days); RSI 49 — healthy momentum range; strong 1-year return of +96.6%; 3-month momentum positive (+6.5%). Currently 14.2% off its 52-week high. Score: +7/7.

Ready to act on this? 📈 Trade on Webull

LXRX is in a confirmed uptrend, trading above both its 50-day ($2.28) and 200-day ($1.74) moving averages. An RSI of 48.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +96.6% compares to +20.5% for SPY (beat the market by 76.1%).

$10,000 invested 1 year ago → $19,658 today
vs. S&P 500 (SPY) — same period beat market by 76.1%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($1.74)
✓Above 50-day MA ($2.28)
✓RSI(14) neutral zone (30–70) — currently 48.6
✓Positive return (+96.6%)
!Within 10% of period high (−14.2%)
Period Range $2.30
$1.03 $2.68
RSI (14) 48.6
0 · OversoldOverbought · 100

Key Metrics

Price$2.30
Period Return+96.6%
Period High$2.68
Period Low$1.03
Drawdown−14.2%
MA-50$2.28
MA-200$1.74
RSI (14)48.6
Avg Volume (30d)2.9M
vs. SPYbeat by 76.1%
Return Rank#131 of 999

Trade LXRX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers